An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestationsof Antiphospholipid Syndrome

  • Gonzalez, Emilio (PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/4/1411/17/17

Funding

  • Quintiles, Inc.: $112,910.00